PharmaBoardroom

Orphan Drugs & Rare Diseases: Argentina

Keen to learn more about orphan drugs & rare diseases in Argentina? Read on! Prepared in association with Marval, O’Farrell & Mairal, a…

David López García – Country Manager, BioMarin Mexico

David López García, Mexico country manager of global rare genetic therapy player Biomarin, outlines the challenging situation around patient access…

Data – The Catch-All Solution for Costly Clinical Trials?

With clinical trials having become extremely expensive to conduct, industry buzz around the potential of data and artificial intelligence (AI) to…

Simona Cocos – General Manager, Zentiva Romania &…

Simona Cocos of Zentiva Romania explains how the affiliate has developed since its separation from Sanofi and how recent acquisitions have impacted…

China: A New Decade

2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese…

Joe Henein – CEO & President, NewBridge…

NewBridge Pharmaceuticals, a specialty pharma company with Dubai as its regional headquarters for the MENA region, is celebrating its 10th anniversary…

Kostas Deligiannis – General Manager Eastern Europe, GE…

Kostas Deligiannis, general manager Eastern Europe for GE Healthcare (GEHC), outlines GE Healthcare's commitment to the 20-country region under his…

PharmaBoardroom’s Women to Watch 2020

To celebrate International Women’s Day 2020, PharmaBoardroom brings you insights from some of the most inspirational female industry leaders we have…

Teun Grooters – CEO & Co-Founder, Arega Pharma,…

Teun Grooters, co-founder and CEO of Arega – the exclusive distributor of Teva generics in Belgium – tells the story of the newly founded…

Pharma Faces: Karim Smaira & Kamel Ghammachi of Genpharm

With a combined experience of over five decades in the pharmaceutical industry including senior executive roles at companies such as Merck and…

Alzheimer’s Disease Treatment: Canadian-Led Innovation…

Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen's aducanumab on the search for Alzheimer's Disease (AD) treatments, and…

The New Belgian Act on Medicinal Product Shortages

On 3 February 2020 the Act of 20 December 2019 amending various legal provisions concerning shortages of medicinal products was published in…

Tagged with GE